Molecular recognition of acetylcholinesterase and its subnanomolar reversible inhibitor: a molecular simulations study

References

• “ADMET Predictor, version 6.0, Simulations Plus, Inc. (2012). www.simulations-plus.com.”
   Google Scholar
• Ago, Y., Koda, K., Takuma, K., & Matsuda, T. (2011). Pharmacological aspects of the acetylcholinesterase inhibitor galantamine. Journal of Pharmacological Sciences, 116(1), 6–17. https://doi.org/https://doi.org/10.1254/jphs.11R01CR
   PubMed Web of Science ®Google Scholar
• Arce, M. P., Rodríguez-Franco, M. I., González-Muñoz, G. C., Pérez, C., López, B., Villarroya, M., López, M. G., García, A. G., & Conde, S. (2009). Neuroprotective and cholinergic properties of multifunctional glutamic acid derivatives for the treatment of Alzheimer’s disease. Journal of Medicinal Chemistry, 52(22), 7249–7257. https://doi.org/https://doi.org/10.1021/jm900628z
   PubMed Web of Science ®Google Scholar
• Barak, D., Kronman, C., Ordentlich, A., Ariel, N., Bromberg, A., Marcus, D., Lazar, A., Velan, B., & Shafferman, A. (1994). Acetylcholinesterase peripheral anionic site degeneracy conferred by amino acid arrays sharing a common core. The Journal of Biological Chemistry, 269(9), 6296–6305. [Online]. Available: http://www.jbc.org/content/269/9/6296.abstract.
   PubMed Web of Science ®Google Scholar
• Bermudez, M., Rakers, C., & Wolber, G. (2015). Structural characteristics of the allosteric binding site represent a key to subtype selective modulators of muscarinic acetylcholine receptors. Molecular Informatics, 34(8), 526–530. https://doi.org/https://doi.org/10.1002/minf.201500025
   PubMed Web of Science ®Google Scholar
• Birks, J. (2006). Cholinesterase inhibitors (ChEIs), donepezil, galantamine and rivastigmine are efficacious for mild to moderate Alzheimer’s disease. Cochrane Database of Systematic Review, (1). https://doi.org/https://doi.org/10.1002/14651858.CD005593. Art No: CD005593.
   Google Scholar
• Bock, A., Bermudez, M., Krebs, F., Matera, C., Chirinda, B., Sydow, D., Dallanoce, C., Holzgrabe, U., De Amici, M., Lohse, M. J., Wolber, G., & Mohr, K. (2016). Ligand binding ensembles determine graded agonist efficacies at a G protein-coupled receptor. Journal of Biological Chemistry, 291(31), 16375–16389. https://doi.org/https://doi.org/10.1074/jbc.M116.735431
   PubMed Web of Science ®Google Scholar
• Bourne, Y., Kolb, H. C., Radić, Z., Sharpless, K. B., Taylor, P., & Marchot, P. (2004). Freeze-frame inhibitor captures acetylcholinesterase in a unique conformation. Proceedings of the National Academy of Sciences of the United States of America, 101(6), 1449–1454. https://doi.org/https://doi.org/10.1073/pnas.0308206100
   PubMed Web of Science ®Google Scholar
• Bourne, Y., Radić, Z., Sulzenbacher, G., Kim, E., Taylor, P., & Marchot, P. (2006). Substrate and product trafficking through the active center gorge of acetylcholinesterase analyzed by crystallography and equilibrium binding. The Journal of Biological Chemistry, 281(39), 29256–29267. https://doi.org/https://doi.org/10.1074/jbc.M603018200
   PubMed Web of Science ®Google Scholar
• Bourne, Y., Taylor, P., Radić, Z., & Marchot, P. (2003). Structural insights into ligand interactions at the acetylcholinesterase peripheral anionic site. The EMBO Journal, 22(1), 1–12. https://doi.org/https://doi.org/10.1093/emboj/cdg005
   PubMed Web of Science ®Google Scholar
• Bui, J. M., Tai, K., & McCammon, J. A. (2004). Acetylcholinesterase: Enhanced fluctuations and alternative routes to the active site in the complex with Fasciculin-2. Journal of the American Chemical Society, 126(23), 7198–7205. https://doi.org/https://doi.org/10.1021/ja0485715
   PubMed Web of Science ®Google Scholar
• Castro, A., & Martinez, A. (2006). Targeting beta-amyloid pathogenesis through acetylcholinesterase inhibitors. Current Pharmaceutical Design, 12(33), 4377–4387. https://doi.org/https://doi.org/10.2174/138161206778792985
   PubMed Web of Science ®Google Scholar
• Cheung, J., Rudolph, M. J., Burshteyn, F., Cassidy, M. S., Gary, E. N., Love, J., Franklin, M. C., & Height, J. J. (2012). Structures of human acetylcholinesterase in complex with pharmacologically important ligands. Journal of Medicinal Chemistry, 55(22), 10282–10286. https://doi.org/https://doi.org/10.1021/jm300871x
   PubMed Web of Science ®Google Scholar
• Chung, Y.-T., & Huang, C.-I. (2012). Ion condensation behavior and dynamics of water molecules surrounding the sodium poly(methacrylic acid) chain in water: a molecular dynamics study. The Journal of Chemical Physics, 136(12), 124903. https://doi.org/https://doi.org/10.1063/1.3697477
   PubMed Web of Science ®Google Scholar
• Colović, M. B., Krstić, D. Z., Lazarević-Pašti, T. D., Bondžić, A. M., & Vasić, V. M. (2013). Acetylcholinesterase inhibitors: Pharmacology and toxicology. Current Neuropharmacology, 11(3), 315–335. https://doi.org/https://doi.org/10.2174/1570159X11311030006
   PubMed Web of Science ®Google Scholar
• Courtney, C. (2004). Long-term donepezil treatment in 565 patients with Alzheimer’s disease (AD2000): Randomised double-blind trial. Lancet, 363(9427), 2105–2115. https://doi.org/https://doi.org/10.1016/S0140-6736(04)16499-4
   PubMed Web of Science ®Google Scholar
• Dolinsky, T. J., Czodrowski, P., Li, H., Nielsen, J. E., Jensen, J. H., Klebe, G., & Baker, N. A. (2007). PDB2PQR: Expanding and upgrading automated preparation of biomolecular structures for molecular simulations. Nucleic Acids Research, 35(Web Server issue), W522–W525. https://doi.org/https://doi.org/10.1093/nar/gkm276
   PubMed Web of Science ®Google Scholar
• Ekholm, M., & Konschin, H. (1999). Comparative model building of human butyrylcholinesterase. Journal of Molecular Structure: Theochem., 467(2), 161–172. https://doi.org/https://doi.org/10.1016/S0166-1280(98)00488-6
   Web of Science ®Google Scholar
• Giacobini, E. (2004). Cholinesterase inhibitors: new roles and therapeutic alternatives. Pharmacological Research, 50(4), 433–440. https://doi.org/https://doi.org/10.1016/j.phrs.2003.11.017
   Google Scholar
• Gibney, G., Camp, S., Dionne, M., MacPhee-Quigley, K., & Taylor, P. (1990). Mutagenesis of essential functional residues in acetylcholinesterase. Proceedings of the National Academy of Sciences of the United States of America, 87(19), 7546–7550. https://doi.org/https://doi.org/10.1073/pnas.87.19.7546
   PubMed Web of Science ®Google Scholar
• Gilson, M. K. (1994). Open & back door in a molecular dynamics simulation of acetylcholinesterase. Science, 263(5151), 1276–1278. https://doi.org/https://doi.org/10.1126/science.8122110
   PubMed Web of Science ®Google Scholar
• Halgren, T. A. (1999). MMFF VI. MMFF94s option for energy minimization studies. Journal of Computational Chemistry, 20(7), 720–729. https://doi.org/https://doi.org/10.1002/(SICI)1096-987X(199905)20:7 < 720::AID-JCC7 > 3.0.CO;2-X
   PubMed Web of Science ®Google Scholar
• Harel, M., Schalk, I., Ehret-Sabatier, L., Bouet, F., Goeldner, M., Hirth, C., Axelsen, P. H., Silman, I., & Sussman, J. L. (1993). Quaternary ligand binding to aromatic residues in the active-site gorge of acetylcholinesterase. Proceedings of the National Academy of Sciences of the United States of America, 90(19), 9031–9035. https://doi.org/https://doi.org/10.1073/pnas.90.19.9031
   PubMed Web of Science ®Google Scholar
• Harris, T. K., & Turner, G. J. (2002). Structural basis of perturbed pKa values of catalytic groups in enzyme active sites. IUBMB Life (International Union of Biochemistry and Molecular Biology: Life), 53(2), 85–98. https://doi.org/https://doi.org/10.1080/15216540211468
   Google Scholar
• Huang, J., Rauscher, S., Nawrocki, G., Ran, T., Feig, M., de Groot, B. L., Grubmüller, H., & MacKerell, A. D. (2017). CHARMM36m: An improved force field for folded and intrinsically disordered proteins. Nature Methods, 14(1), 71–73. https://doi.org/https://doi.org/10.1038/nmeth.4067
   PubMed Web of Science ®Google Scholar
• Humphrey, W., Dalke, A., & Schulten, K. (1996). VMD: Visual molecular dynamics. Journal of Molecular Graphics, 14(1), 33–38. https://doi.org/https://doi.org/10.1016/0263-7855(96)00018-5
   PubMedGoogle Scholar
• Jo, S., Kim, T., Iyer, V. G., & Im, W. (2008). CHARMM-GUI: A web-based graphical user interface for CHARMM. Journal of Computational Chemistry, 29(11), 1859–1865. https://doi.org/https://doi.org/10.1002/jcc.20945
   PubMed Web of Science ®Google Scholar
• Koellner, G., Kryger, G., Millard, C. B., Silman, I., Sussman, J. L., & Steiner, T. (2000). Active-site gorge and buried water molecules in crystal structures of acetylcholinesterase from Torpedo Californica. Journal of Molecular Biology, 296(2), 713–735. https://doi.org/https://doi.org/10.1006/jmbi.1999.3468
   PubMed Web of Science ®Google Scholar
• Korb, T. E. E. O., & Stützle, T. (2006). Plants: Application of ant colony optimization to structure-based drug design. In M. Dorigo, L. M. Gambardella, M. Birattari, A. Martinoli, R. Poli, T. Stutzle (eds.). Ant Colony Optimization and Swarm Intelligence. ANTS 2006. Lecture Notes in Computer Science (Vol. 4150, pp. 247–258). Springer.
   Google Scholar
• Kreienkamp, H. J., Weise, C., Raba, R., Aaviksaar, A., & Hucho, F. (1991). Anionic subsites of the catalytic center of acetylcholinesterase from Torpedo and from cobra venom. Proceedings of the National Academy of Sciences of the United States of America, 88(14), 6117–6121. https://doi.org/https://doi.org/10.1073/pnas.88.14.6117
   PubMed Web of Science ®Google Scholar
• Mishra, P., Kumar, A., & Panda, G. (2019). Anti-cholinesterase hybrids as multi-target-directed ligands against Alzheimer's disease (1998-2018)). Bioorganic & Medicinal Chemistry, 27(6), 895–930. https://doi.org/https://doi.org/10.1016/j.bmc.2019.01.025
   PubMed Web of Science ®Google Scholar
• Ordentlich, A. (1993). Dissection of the human acetylcholinesterase active center determinants of substrate specificity. Identification of residues constituting the anionic site, the hydrophobic site, and the acyl pocket. The Journal of Biological Chemistry, 268(23), 17083–17095. [Online]. Available: http://www.jbc.org/content/268/23/17083.abstract.
   PubMed Web of Science ®Google Scholar
• Ordentlich, A., Barak, D., Kronman, C., Ariel, N., Segall, Y., Velan, B., & Shafferman, A. (1998). Functional characteristics of the oxyanion hole in human acetylcholinesterase. The Journal of Biological Chemistry, 273(31), 19509–19517. [Online]. Available: http://www.jbc.org/content/273/31/19509.abstract. https://doi.org/https://doi.org/10.1074/jbc.273.31.19509
   PubMed Web of Science ®Google Scholar
• Pedretti, A., Villa, L., & Vistoli, G. (2004). VEGA-an open platform to develop chemo-bio-informatics applications, using plug-in architecture and script programming. Journal of Computer-Aided Molecular Design, 18(3), 167–173. https://doi.org/https://doi.org/10.1023/B:JCAM.0000035186.90683.f2
   PubMed Web of Science ®Google Scholar
• Petukh, M., Stefl, S., & Alexov, E. (2013). The role of protonation states in ligand-receptor recognition and binding. Current Pharmaceutical Design, 19(23), 4182–4190. https://doi.org/https://doi.org/10.2174/1381612811319230004
   PubMed Web of Science ®Google Scholar
• Phillips, J. C., Braun, R., Wang, W., Gumbart, J., Tajkhorshid, E., Villa, E., Chipot, C., Skeel, R. D., Kalé, L., & Schulten, K. (2005). Scalable molecular dynamics with NAMD. Journal of Computational Chemistry, 26(16), 1781–1802. https://doi.org/https://doi.org/10.1002/jcc.20289
   PubMed Web of Science ®Google Scholar
• Quinn, D. M. (1987). Acetylcholinesterase: Enzyme structure, reaction dynamics, and virtual transition states. Chemical Reviews, 87(5), 955–979. https://doi.org/https://doi.org/10.1021/cr00081a005
   Web of Science ®Google Scholar
• Radic, Z., Gibney, G., Kawamoto, S., MacPhee-Quigley, K., Bongiorno, C., & Taylor, P. (1992). Expression of recombinant acetylcholinesterase in a baculovirus system: Kinetic properties of glutamate 199 mutants. Biochemistry, 31(40), 9760–9767. https://doi.org/https://doi.org/10.1021/bi00155a032
   PubMed Web of Science ®Google Scholar
• Radić, Z., Kirchhoff, P. D., Quinn, D. M., McCammon, J. A., & Taylor, P. (1997). Electrostatic influence on the kinetics of ligand binding to acetylcholinesterase. Distinctions between active center ligands and fasciculin. The Journal of Biological Chemistry, 272(37), 23265–23277. https://doi.org/https://doi.org/10.1074/jbc.272.37.23265
   PubMed Web of Science ®Google Scholar
• Shafferman, A., Velan, B., Ordentlich, A., Kronman, C., Grosfeld, H., Leitner, M., Flashner, Y., Cohen, S., Barak, D., & Ariel, N. (1992). Substrate inhibition of acetylcholinesterase: Residues affecting signal transduction from the surface to the catalytic center. The Embo Journal, 11(10), 3561–3568. https://doi.org/https://doi.org/10.1002/j.1460-2075.1992.tb05439.x
   PubMed Web of Science ®Google Scholar
• Spyrakis, F., Dellafiora, L., Da, C., Kellogg, G. E., & Cozzini, P. (2013). Correct protonation states and relevant waters = better computational simulations? Current Pharmaceutical Design, 19(23), 4291–4309. https://doi.org/https://doi.org/10.2174/1381612811319230011
   PubMed Web of Science ®Google Scholar
• Stewart, J. J. P. (2013). Optimization of parameters for semiempirical methods VI: More modifications to the NDDO approximations and re-optimization of parameters. Journal of Molecular Modeling, 19(1), 1–32. https://doi.org/https://doi.org/10.1007/s00894-012-1667-x
   PubMed Web of Science ®Google Scholar
• Sussman, J. L., Harel, M., Frolow, F., Oefner, C., Goldman, A., Toker, L., & Silman, I. (1991). Atomic structure of acetylcholinesterase from Torpedo Californica: A prototypic acetylcholine-binding protein. Science (New York, N.Y.), 253(5022), 872–879. https://doi.org/https://doi.org/10.1126/science.1678899
   PubMed Web of Science ®Google Scholar
• Sydow, D. (2015). Dznophores: Novel dynamic pharmacophores. Humboldt-Universitat zu Berlin.
   Google Scholar
• Taylor, P., & Lappi, S. (1975). Interaction of fluorescence probes with acetylcholinesterase. The site and specificity of propidium binding. Biochemistry, 14(9), 1989–1997. https://doi.org/https://doi.org/10.1021/bi00680a029
   PubMed Web of Science ®Google Scholar
• Taylor, P., & Radic, Z. (1994). The cholinesterases: From genes to proteins. Annual Review of Pharmacology and Toxicology, 34(1), 281–320. https://doi.org/https://doi.org/10.1146/annurev.pa.34.040194.001433
   PubMedGoogle Scholar
• Trott, O., & Olson, A. J. (2010). AutoDock Vina: Improving the speed and accuracy of docking with a new scoring function, efficient optimization, and multithreading. Journal of Computational Chemistry, 31(2), 455–461. https://doi.org/https://doi.org/10.1002/jcc.21334
   PubMed Web of Science ®Google Scholar
• Vanommeslaeghe, K., Hatcher, E., Acharya, C., Kundu, S., Zhong, S., Shim, J., Darian, E., Guvench, O., Lopes, P., Vorobyov, I., & Mackerell, A. D. (2010). CHARMM general force field: A force field for drug-like molecules compatible with the CHARMM all-atom additive biological force fields. Journal of Computational Chemistry, 31(4), 671–690. https://doi.org/https://doi.org/10.1002/jcc.21367
   PubMed Web of Science ®Google Scholar
• Vellom, D. C., Radic, Z., Li, Y., Pickering, N. A., Camp, S., & Taylor, P. (1993). Amino acid residues controlling acetylcholinesterase and butyrylcholinesterase specificity. Biochemistry, 32(1), 12–17. https://doi.org/https://doi.org/10.1021/bi00052a003
   PubMed Web of Science ®Google Scholar
• Vitorović-Todorović, M. D., Cvijetić, I. N., Juranić, I. O., & Drakulić, B. J. (2012). The 3D-QSAR study of 110 diverse, dual binding, acetylcholinesterase inhibitors based on alignment independent descriptors (GRIND-2). the effects of conformation on predictive power and interpretability of the models. Journal of Molecular Graphics and Modelling, 38, 194–210. https://doi.org/https://doi.org/10.1016/j.jmgm.2012.08.001
   Google Scholar
• Vitorović-Todorović, M. D., Worek, F., Perdih, A., Bauk, S. Đ., Vujatović, T. B., & Cvijetić, I. N. (2019). The in vitro protective effects of the three novel nanomolar reversible inhibitors of human cholinesterases against irreversible inhibition by organophosphorous chemical warfare agents. Chemico-Biological Interactions., 30. https://doi.org/https://doi.org/10.1016/j.cbi.2019.06.027
   Google Scholar
• Waterhouse, A., Bertoni, M., Bienert, S., Studer, G., Tauriello, G., Gumienny, R., Heer, F. T., de Beer, T. A. P., Rempfer, C., Bordoli, L., Lepore, R., & Schwede, T. (2018). SWISS-MODEL: Homology modelling of protein structures and complexes. Nucleic Acids Research, 46(W1), W296–W303. https://doi.org/https://doi.org/10.1093/nar/gky427
   PubMed Web of Science ®Google Scholar
• Watkins, P. B. (1994). Hepatotoxic effects of tacrine administration in patients with Alzheimer’s disease. JAMA: The Journal of the American Medical Association, 271(13), 992–998. https://doi.org/https://doi.org/10.1001/jama.271.13.992
   PubMed Web of Science ®Google Scholar
• Winblad, B., Kilander, L., Eriksson, S., Minthon, L., Båtsman, S., Wetterholm, A.-L., Jansson-Blixt, C., & Haglund, A., Severe Alzheimer’s Disease Study Group (2006). Donepezil in patients with severe Alzheimer’s disease: Double-blind, parallel-group, placebo-controlled study. Lancet (London, England), 367(9516), 1057–1065. https://doi.org/https://doi.org/10.1016/S0140-6736(06)68350-5
   PubMed Web of Science ®Google Scholar
• Wlodek, S. T., Clark, T. W., Scott, L. R., & McCammon, J. A. (1997). Molecular dynamics of acetylcholinesterase dimer complexed with tacrine. Journal of the American Chemical Society, 119(40), 9513–9522. https://doi.org/https://doi.org/10.1021/ja971226d
   Web of Science ®Google Scholar
• Wolber, G., & Langer, T. (2005). LigandScout: 3D pharmacophores derived from protein-bound ligands and their use as virtual screening filters. Journal of Chemical Information and Modeling, 45(1), 160–169. https://doi.org/https://doi.org/10.1021/ci049885e
   PubMed Web of Science ®Google Scholar
• Xu, Y., Colletier, J.-P., Weik, M., Jiang, H., Moult, J., Silman, I., & Sussman, J. L. (2008). Flexibility of aromatic residues in the active-site gorge of acetylcholinesterase: X-ray versus molecular dynamics. Biophysical Journal, 95(5), 2500–2511. https://doi.org/https://doi.org/10.1529/biophysj.108.129601
   PubMed Web of Science ®Google Scholar
• Zhou, H.-X., Wlodek, S. T., & McCammon, J. A. (1998). Conformation gating as a mechanism for enzyme specificity. Proceedings of the National Academy of Sciences of the United States of America, 95(16), 9280–9283. https://doi.org/https://doi.org/10.1073/pnas.95.16.9280
   PubMed Web of Science ®Google Scholar